We are deeply engaged in investments in new scientific developments in the areas of biotech, healthcare, technology, fintech, and disruptive technologies across all sectors. We pursue these efforts through direct and co-investments with other family offices and institutional investors. Our investments include start-ups, later-stage private companies, and public companies directly and through hedge, private equity, and venture funds.

Science

Sofia Sakopoulos joined the R Liping Office as a healthcare and biotechnology investment analyst. She received a Bachelor of Science in Behavioral Neuroscience with honors and a Master of Arts in Clinical Psychology with a concentration in Mental Health and Substance Abuse Counseling. She is currently a doctoral student for Clinical Psychology. Ms. Sakopoulos has had extensive molecular neuroscience research experience with the Stanley Center for Psychiatric Research at the Broad Institute of MIT & Harvard. She conducts psychological research focused on brain health and the integration of cutting-edge pharmacological science and psychological interventions for an effective understanding of treatment interventions for brain circuitry and neural mechanisms associated with advanced psychopathologies.

Ms. Sakopoulos is active in portfolio investments in healthcare, biotechnology, hedge funds, private equity, and venture. She co-leads the Women in Family Office Group that focuses on women in the family office space and creates a close community through events and conferences. Her personal interests include traveling, sports, the arts, and philanthropy, in which she volunteers her time to coach tennis to children living in the projects in Brooklyn, New York.

Sofia Sakopoulos, MA, PhD(c), Senior Investment Officer